Effects of Magnoliae Flos on Atopic Dermatitis-Like Inflammation Evaluated via Extracellular Signal-regulated Kinase or Signal Transducers and Activators of Transcription 1/3 Signalling Pathways
DOI:
https://doi.org/10.2340/actadv.v103.11593Keywords:
Atopic dermatitis, Inflammation, Magnoliae flos, MAPK, STATsAbstract
Atopic dermatitis is a chronic inflammatory skin disease. Skin is the largest organ and plays a pivotal role in protecting the body. Not only does the skin act as a physical barrier against the external environment, but it also has its own immune system. Atopic dermatitis is caused by prolonged excessive inflammatory responses that worsen under imbalanced cutaneous immune system skin conditions. Although the prevalence and burden of atopic dermatitis is increasing, the standard therapeutic agents remain unclear due to the complicated pathophysiology of the condition. The objective of this study is to examine the use of Magnoliae flos, the dried flower bud of Magnolia biondii or related plants. The effects and underlying mechanism of action of aqueous extract of the buds of Magnoliae flos (MF) were evaluated. Immortalized human keratinocytes (HaCaT) stimulated with tumour necrosis factor-α and interferon-γ mixture and NC/Nga mice stimulated with 2,4-dinitrochlorobenzene were used as atopic dermatitis models, in vitro and in vivo, respectively. The effects of MF were determined by measuring the suppression of pro-inflammatory signalling pathways, such as extracellular signal-regulated kinase or signal transducers and activators of transcription 1/3 and restoring skin barrier molecules. In conclusion, MF is a potential therapeutic alternative for the treatment of atopic dermatitis through repressing inflammatory pathways.
Downloads
References
Puar N, Chovatiya R, Paller AS. New treatments in atopic dermatitis. Ann Allergy Asthma Immunol 2021; 126: 21-31.
https://doi.org/10.1016/j.anai.2020.08.016 DOI: https://doi.org/10.1016/j.anai.2020.08.016
Leung DY, Geha RS. Immunoregulatory abnormalities in atopic dermatitis. Clin Rev Allergy 1986; 4: 67-86.
https://doi.org/10.1007/BF02991188 DOI: https://doi.org/10.1007/BF02991188
Czarnowicki T, Krueger JG, Guttman-Yassky E. Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march. J Allergy Clin Immunol 2017; 139: 1723-1734.
https://doi.org/10.1016/j.jaci.2017.04.004 DOI: https://doi.org/10.1016/j.jaci.2017.04.004
Ständer S. Atopic dermatitis. N Engl J Med 2021; 384: 1136-1143.
https://doi.org/10.1056/NEJMra2023911 DOI: https://doi.org/10.1056/NEJMra2023911
Seth D, Cheldize K, Brown D, Freeman EF. Global burden of skin disease: inequities and innovations. Curr Dermatol Rep 2017; 6: 204-210.
https://doi.org/10.1007/s13671-017-0192-7 DOI: https://doi.org/10.1007/s13671-017-0192-7
Kader HA, Azeem M, Jwayed SA, Al-Shehhi A, Tabassum A, Ayoub MA, et al. Current insights into immunology and novel therapeutics of atopic dermatitis. Cells 2021; 10: 1392.
https://doi.org/10.3390/cells10061392 DOI: https://doi.org/10.3390/cells10061392
Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet 2020; 396: 345-360.
https://doi.org/10.1016/S0140-6736(20)31286-1 DOI: https://doi.org/10.1016/S0140-6736(20)31286-1
Frazier W, Bhardwaj N. Atopic dermatitis: diagnosis and treatment. Am Fam Physician 2020; 101: 590-598.
Coondoo A, Phiske M, Verma S, Lahiri K. Side-effects of topical steroids: a long overdue revisit. Indian Dermatol Online J 2014; 5: 416-425.
https://doi.org/10.4103/2229-5178.142483 DOI: https://doi.org/10.4103/2229-5178.142483
Gomez-Garcia F, Gomez-Arias PJ, Hernandez J, Montilla AM, Gay-Mimbrera J, Aguilar-Luque M, et al. Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review. BMJ Open 2019; 9: e028303.
https://doi.org/10.1136/bmjopen-2018-028303 DOI: https://doi.org/10.1136/bmjopen-2018-028303
Ferreira S, Guttman-Yassky E, Torres T. Selective JAK1 inhibitors for the treatment of atopic dermatitis: focus on upadacitinib and abrocitinib. Am J Clin Dermatol 2020; 21: 783-798.
https://doi.org/10.1007/s40257-020-00548-6 DOI: https://doi.org/10.1007/s40257-020-00548-6
Kim HJ, Nam YR, Nam JH. Flos Magnoliae inhibits chloride secretion via ANO1 inhibition in Calu-3 cells. Am J Chin Med 2018; 46: 1079-1092.
https://doi.org/10.1142/S0192415X18500568 DOI: https://doi.org/10.1142/S0192415X18500568
Ma P, Che D, Zhao T, Zhang Y, Li C, An H, et al. Magnolin inhibits IgE/Ag-induced allergy in vivo and in vitro. Int Immunopharmacol 2019; 76: 105867.
https://doi.org/10.1016/j.intimp.2019.105867 DOI: https://doi.org/10.1016/j.intimp.2019.105867
Kim JY, Lim HJ, Lee da Y, Kim JS, Kim DH, Lee HJ, et al. In vitro anti-inflammatory activity of lignans isolated from Magnolia fargesii. Bioorg Med Chem Lett 2009; 19: 937-940.
https://doi.org/10.1016/j.bmcl.2008.11.103 DOI: https://doi.org/10.1016/j.bmcl.2008.11.103
An HJ, Kim JY, Kim WH, Gwon MG, Gu HM, Jeon MJ, et al. Therapeutic effects of bee venom and its major component, melittin, on atopic dermatitis in vivo and in vitro. Br J Pharmacol 2018; 175: 4310-4324.
https://doi.org/10.1111/bph.14487 DOI: https://doi.org/10.1111/bph.14487
Gittler JK, Shemer A, Suarez-Farinas M, Fuentes-Duculan J, Gulewicz KJ, Wang CQ, et al. Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. J Allergy Clin Immunol 2012; 130: 1344-1354.
https://doi.org/10.1016/j.jaci.2012.07.012 DOI: https://doi.org/10.1016/j.jaci.2012.07.012
Coondoo A. The role of cytokines in the pathomechanism of cutaneous disorders. Indian J Dermatol 2012; 57: 90-96.
https://doi.org/10.4103/0019-5154.94272 DOI: https://doi.org/10.4103/0019-5154.94272
Boguniewicz M, Leung DY. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 2011; 242: 233-246.
https://doi.org/10.1111/j.1600-065X.2011.01027.x DOI: https://doi.org/10.1111/j.1600-065X.2011.01027.x
Di Paolo CT, Diamandis EP, Prassas I. The role of kallikreins in inflammatory skin disorders and their potential as therapeutic targets. Crit Rev Clin Lab Sci 2021; 58: 1-16.
https://doi.org/10.1080/10408363.2020.1775171 DOI: https://doi.org/10.1080/10408363.2020.1775171
Gil TY, Hong CH, An HJ. Anti-inflammatory effects of ellagic acid on keratinocytes via MAPK and STAT pathways. Int J Mol Sci 2021; 22: 1277.
https://doi.org/10.3390/ijms22031277 DOI: https://doi.org/10.3390/ijms22031277
Liu YJ, Soumelis V, Watanabe N, Ito T, Wang YH, Malefyt Rde W, et al. TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Annu Rev Immunol 2007; 25: 193-219.
https://doi.org/10.1146/annurev.immunol.25.022106.141718 DOI: https://doi.org/10.1146/annurev.immunol.25.022106.141718
Ye J, Piao H, Jiang J, Jin G, Zheng M, Yang J, et al. Polydatin inhibits mast cell-mediated allergic inflammation by targeting PI3K/Akt, MAPK, NF-kappaB and Nrf2/HO-1 pathways. Sci Rep 2017; 7: 11895.
https://doi.org/10.1038/s41598-017-12252-3 DOI: https://doi.org/10.1038/s41598-017-12252-3
Montilla AM, Gomez-Garcia F, Gomez-Arias PJ, Gay-Mimbrera J, Hernandez-Parada J, Isla-Tejera B, et al. Scoping review on the use of drugs targeting JAK/STAT pathway in atopic dermatitis, vitiligo, and alopecia areata. Dermatol Ther 2019; 9: 655-683.
https://doi.org/10.1007/s13555-019-00329-y DOI: https://doi.org/10.1007/s13555-019-00329-y
Jin H, He R, Oyoshi M, Geha RS. Animal models of atopic dermatitis. J Invest Dermatol 2009; 129: 31-40.
https://doi.org/10.1038/jid.2008.106 DOI: https://doi.org/10.1038/jid.2008.106
Pavlis J, Yosipovitch G. Management of itch in atopic dermatitis. Am J Clin Dermatol 2018; 19: 319-332.
https://doi.org/10.1007/s40257-017-0335-4 DOI: https://doi.org/10.1007/s40257-017-0335-4
Huang Y, Zou X, Zhang X, Wang F, Zhu W, Zhang G, et al. Magnolin inhibits prostate cancer cell growth in vitro and in vivo. Biomed Pharmacother 2017; 87: 714-720.
https://doi.org/10.1016/j.biopha.2017.01.010 DOI: https://doi.org/10.1016/j.biopha.2017.01.010
Wang L, Zhao Z, Zhao H, Liu M, Lin C, Li L, et al. Pectin polysaccharide from flos magnoliae (Xin Yi, magnolia biondii pamp. flower buds): hot-compressed water extraction, purification and partial structural characterization. Food Hydrocolloids 2022; 122: 107061.
https://doi.org/10.1016/j.foodhyd.2021.107061 DOI: https://doi.org/10.1016/j.foodhyd.2021.107061
Lee CJ, Lee MH, Yoo SM, Choi KI, Song JH, Jang JH, et al. Magnolin inhibits cell migration and invasion by targeting the ERKs/RSK2 signaling pathway. BMC Cancer 2015; 15: 576.
https://doi.org/10.1186/s12885-015-1580-7 DOI: https://doi.org/10.1186/s12885-015-1580-7
Kim JS, Kim JY, Lee HJ, Lim HJ, Lee DY, Kim DH, et al. Suppression of inducible nitric oxide synthase expression by furfuran lignans from flower buds of Magnolia fargesii in BV-2 microglial cells. Phytother Res 2010; 24: 748-753.
https://doi.org/10.1002/ptr.3028 DOI: https://doi.org/10.1002/ptr.3028
Bantz SK, Zhu Z, Zheng T. The Atopic march: progression from atopic dermatitis to allergic rhinitis and asthma. J Clin Cell Immunol 2014; 5: 202.
Spergel JM. Atopic march: link to upper airways. Curr Opin Allergy Clin Immunol 2005; 5: 17-21.
https://doi.org/10.1097/00130832-200502000-00005 DOI: https://doi.org/10.1097/00130832-200502000-00005
Abe S, Yuasa K. Sudachitin, a polymethoxyflavone from Citrus sudachi, induces apoptosis via the regulation of MAPK pathways in human keratinocyte HaCaT cells. Biochem Biophys Res Commun 2019; 519: 344-350.
https://doi.org/10.1016/j.bbrc.2019.09.010 DOI: https://doi.org/10.1016/j.bbrc.2019.09.010
Lee K-S, Jeong E-S, Heo S-H, Seo J-H, Jeong D-G, Choi Y-K. A novel model for human atopic dermatitis: application of repeated DNCB patch in BALB/c mice, in comparison with NC/Nga mice. Lab Anim Res 2010; 26: 95-102.
https://doi.org/10.5625/lar.2010.26.1.95 DOI: https://doi.org/10.5625/lar.2010.26.1.95
Voisin T, Chiu IM. Mast cells get on your nerves in itch. Immunity 2019; 50: 1117-1119.
https://doi.org/10.1016/j.immuni.2019.04.007 DOI: https://doi.org/10.1016/j.immuni.2019.04.007
Wang SH, Zuo YG. Thymic stromal lymphopoietin in cutaneous immune-mediated diseases. Front Immunol 2021; 12: 698522.
https://doi.org/10.3389/fimmu.2021.698522 DOI: https://doi.org/10.3389/fimmu.2021.698522
Xia Q, Liu T, Wang J, Sun L, Chen X, Liu Y, et al. Mast cells and thymic stromal lymphopoietin (TSLP) expression positively correlates with pruritus intensity in dermatitis herpetiformis. Eur J Dermatol 2020; 30: 499-504.
https://doi.org/10.1684/ejd.2020.3881 DOI: https://doi.org/10.1684/ejd.2020.3881
Masuoka M, Shiraishi H, Ohta S, Suzuki S, Arima K, Aoki S, et al. Periostin promotes chronic allergic inflammation in response to Th2 cytokines. J Clin Invest 2012; 122: 2590-2600.
https://doi.org/10.1172/JCI58978 DOI: https://doi.org/10.1172/JCI58978
Gutowska-Owsiak D, de La Serna JB, Fritzsche M, Naeem A, Podobas EI, Leeming M, et al. Orchestrated control of filaggrin-actin scaffolds underpins cornification. Cell Death Dis 2018; 9: 412.
https://doi.org/10.1038/s41419-018-0407-2 DOI: https://doi.org/10.1038/s41419-018-0407-2
Lee HJ, Lee SH. Epidermal permeability barrier defects and barrier repair therapy in atopic dermatitis. Allergy Asthma Immunol Res 2014; 6: 276-287.
https://doi.org/10.4168/aair.2014.6.4.276 DOI: https://doi.org/10.4168/aair.2014.6.4.276
Morizane S. The role of kallikrein-related peptidases in atopic dermatitis. Acta Med Okayama 2019; 73: 1-6.
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2023 Tae-Young Gil, Bo-Ram Jin, Yea-Jin Park, Hye-Min Kim, Hyo-Jin An
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
Funding data
-
National Research Foundation of Korea
Grant numbers NRF-2021R1F1A1058077
